Innate Immunity and Inflammation in NAFLD/NASH

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and hepatocyte injury.
• Innate immune system activation is a critical driver of liver inflammation in NASH.
• Understanding immune cell recognition of damage signals is vital for NASH therapeutics.

Purpose of the Study:

• To review current understanding of inflammatory mechanisms in NASH.
• To explore the role of sterile cell death and gut-liver axis dysfunction.
• To summarize therapeutic strategies targeting inflammatory pathways in NASH.

Main Methods:

• Literature review focusing on innate immunity, cell death, and gut-liver axis in NASH.
• Analysis of pattern recognition receptor (PRR) signaling in liver inflammation.
• Synthesis of data on therapeutic targets for NASH.

Main Results:

• Lipotoxicity-induced sterile cell death in hepatocytes contributes to NASH inflammation.
• Gut leakiness allows bacterial product translocation, activating liver immunity.
• Immune cells recognize damage- and pathogen-associated molecular patterns via PRRs, amplifying injury.

Conclusions:

• Modulating inflammatory signaling pathways presents promising therapeutic avenues for NASH.
• Targeting sterile cell death and gut-liver axis may mitigate NASH progression.
• Further research into immune cell-mediated mechanisms is crucial for effective NASH treatment.